» Articles » PMID: 25332796

Percutaneous Coronary Intervention Causes a Rapid but Transient Mobilisation of CD34(+)CD45(-) Cells

Overview
Journal Open Heart
Date 2014 Oct 22
PMID 25332796
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Circulating CD34(+)CD45(-) cell concentrations are increased in patients with coronary artery disease, however their pathophysiological significance is unknown. We determined CD34(+)CD45(-) cell concentrations following percutaneous coronary intervention (PCI) in order to explore their role in acute vascular injury.

Methods: In a prospective time-course analysis, we quantified using flow cytometry circulating CD34(+)CD45(-) cells, traditional CD34(+)VEGFR-2(+) putative endothelial progenitor cells (EPCs), CD14(+) VEGFR(-) 2(+)Tie-2(+) angiogenic monocytes and intercellular adhesion molecule expression (CXCR-4 and CD18) in patients, before and during the first week following diagnostic angiography (n=13) or PCI (n=23). Vascular endothelial growth factor-A (VEGF-A) and C reactive protein (CRP) were quantified by ELISA.

Results: Unlike diagnostic angiography, PCI increased circulating neutrophil and CRP concentrations at 24 and 48 h, respectively (p<0.002 for both). CD34(+)CD45(-) cell concentrations were unaffected by angiography (p>0.4), but were transiently increased 6 h following PCI (median (IQR) 0.93 (0.43-1.49) vs 1.51 (0.96-2.15)×10(6) cells/L; p=0.01), returning to normal by 24 h. This occurred in the absence of any change in serum VEFG-A concentration, adhesion molecule expression on CD34(+) cells, or mobilisation of traditional EPCs or angiogenic monocytes (p>0.1 for all).

Conclusions: PCI transiently increases circulating CD34(+)CD45(-) cells, without increasing CD34(+) adhesion molecule expression or VEGF-A concentrations, suggesting that CD34(+)CD45(-) cells may be mobilised from the vessel wall directly as a result of mechanical injury. Traditional putative EPC and angiogenic monocytes are unaffected by PCI, and are unlikely to be important in the acute response to vascular injury.

Citing Articles

Endothelial progenitor cells and coronary artery disease: Current concepts and future research directions.

Xiao S, Kuang C World J Clin Cases. 2021; 9(30):8953-8966.

PMID: 34786379 PMC: 8567528. DOI: 10.12998/wjcc.v9.i30.8953.


Endothelial Progenitor Cell Biology and Vascular Recovery Following Transradial Cardiac Catheterization.

Mitchell A, Fujisawa T, Mills N, Brittan M, Newby D, Cruden N J Am Heart Assoc. 2017; 6(11).

PMID: 29080864 PMC: 5721759. DOI: 10.1161/JAHA.117.006610.


Increased serum levels of fractalkine and mobilisation of CD34CD45 endothelial progenitor cells in systemic sclerosis.

Benyamine A, Magalon J, Cointe S, Lacroix R, Arnaud L, Bardin N Arthritis Res Ther. 2017; 19(1):60.

PMID: 28320472 PMC: 5359964. DOI: 10.1186/s13075-017-1271-7.

References
1.
Pelliccia F, Cianfrocca C, Rosano G, Mercuro G, Speciale G, Pasceri V . Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study. JACC Cardiovasc Interv. 2010; 3(1):78-86. DOI: 10.1016/j.jcin.2009.10.020. View

2.
Hokimoto S, Oike Y, Saito T, Kitaoka M, Oshima S, Noda K . Increased expression of monocyte chemoattractant protein-1 in atherectomy specimens from patients with restenosis after percutaneous transluminal coronary angioplasty. Circ J. 2002; 66(1):114-6. DOI: 10.1253/circj.66.114. View

3.
Case J, Mead L, Bessler W, Prater D, White H, Saadatzadeh M . Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007; 35(7):1109-18. DOI: 10.1016/j.exphem.2007.04.002. View

4.
Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T . Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation. 2007; 115(5):553-61. DOI: 10.1161/CIRCULATIONAHA.106.621714. View

5.
Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A . Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005; 353(10):999-1007. DOI: 10.1056/NEJMoa043814. View